Intrahepatic cholangiocarcinoma
Intrahepatic cholangiocarcinoma
复制标题
DOI：
10.2174/9781681082851116010019
复制
发表时间：
2014-10
期刊：
影响因子：
--
通讯作者：
Jan Gerstenmaier
中科院分区：
文献类型：
--
作者：
Jan Gerstenmaier
所有ICC患者均为晚期无法治愈的疾病（Shaib等人，2007年）。即使ICC患者完全手术切除，复发率仍然很高，5年生存率不利（Kawarada et al., 2002; Anderson et al., 2004）。因此，ICC是一种生长缓慢但高度转移的癌症，是ICC患者死亡的主要原因。据报道，全球与ICC相关的死亡率和ICC发病率有所上升（Khan等人，2002年；Patel， 2002年）。ICC患者的预后
all patients with ICC present with advanced, incurable disease (Shaib et al., 2007). Even ICC patients who have undergone complete surgical resection, the recurrence rate remains quite high and the 5-year survival rate is unfavorable (Kawarada et al., 2002; Anderson et al., 2004). Therefore, ICC is a slow growing but highly metastatic cancer, which is the major cause of death in ICC patients. A global increase in ICC related mortality and incidence of ICC have been reported (Khan et al., 2002; Patel, 2002). The prognosis for patients with ICC